Nicole Mccardle CCSS

Recommended Articles

• New Blood Test May Help to Differentiate Between Celiac and Gluten Sensitivity

  Celiac disease is a rare autoimmune illness, where the immune system starts attacking the outer layer of intestine once gluten is ingested. However, people complaining about gastrointestinal problems after gluten consumption far exceed the number of people living with celiac, these are mostly people...

• What Causes Nausea: An Overview of the Most Common Conditions

  Nausea is a term which describes a sick stomach and the feeling of wanting to vomit. It can be a sign to vomit the contents of the stomach. Nausea is a symptom, not a disease. It is caused by many diseases but can often be prevented. Almost all people experience nausea at some point, which makes it...

• NBC Today's Hoda Kotb Opens Up About Her Personal Fight with Breast Cancer

  For Hoda Kotb, cancer brought something to her life that ended up saving her. Most people know Hoda Kotb as the positive and energetic co-anchor of NBC News TODAY, but what people don't know is that she didn't always live her life this way.Back in her early 40s, Hoda was going through a tough time....

• Health Benefits of Kale

  Kale contains a multitude of nutrients and minerals that are beneficial for the human body. The consumption of kale accounts for 200 percent of the daily recommended levels of vitamin C. A cup of chopped kale contains only 33 calories, but provides various nutrients, like calcium, vitamin A,...

• Comparisons Between Duchenne and Becker Muscular Dystrophy

  Muscular dystrophy is an inherited disease caused by abnormal levels of dystrophin in the body, a protein necessary for maintaining muscle integrity for movement and for heart functions. It is characterized by progressive muscle atrophy and is also linked to a heart condition called cardiomyopathy. ...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...